Comprehensive coverage

Alzheimer's

Researchers report new compounds that appear to be able to mimic the physical drive of exercise—at least in rodent cells. This discovery may lead to a new way to treat muscular dystrophy and other medical conditions in people,
Neurological morbidity is the world's number 1 cause of morbidity and disability, with over 3 billion people with brain diseases * according to an article published this weekend in the Lancet. The scope of morbidity and disability has grown since then
Toxic proteins accumulate in the brains of Alzheimer's patients. In the familial Alzheimer's patients, the accumulation mechanism is clear since there is a circumstantial relationship between the mutations and the identity of the defective proteins. In the random disease, on the other hand, the cause of the accumulation of proteins
The proteins and mechanisms required to fight the protein accumulations that lead to neurodegenerative diseases have been identified
This is the first time that researchers succeed in developing personalized tools for infectious diseases, which until now have only been developed for specific diseases such as cancer and Alzheimer's
Degeneration of the cells of the immune system in the brain may be the biological cause of depression, and there may be substances that can restore these cells - and be antidepressants
Professor Hermona Sorek, one of the world's leading researchers of gene expression in the brain, was able to find, in collaboration with her research colleagues, a molecular mechanism that occurs in the brains of Alzheimer's patients, which does not occur in men and which explains the acceleration
Prof. Schwartz challenged the convention that nerve cells do not regenerate or recover, and discovered that the immune system also takes care of them. She also studied the blood-brain barrier and discovered that it is prevented
The research carried out at Ben Gurion University focused on the VDAC1 protein that controls mitochondrial activity and controls cell life and death
The living brain project of Dassault Systèmes makes it possible to develop treatments for epilepsy patients who do not respond to drugs, says John McCarthy, head of life sciences and health at Dassault Systèmes in an interview with the science website at the CES conference
A seminal 2006 article in Nature claiming that beta-amyloid protein was primarily responsible for Alzheimer's was found to be partially fabricated. Long years of attempts to develop medicines were lost in vain * Twenty more articles are now being examined
Disruption of the activity rate of neural networks is related to the development of Alzheimer's disease
Recently, Weizmann Institute of Science scientists compared neural networks of female and male worms, and discovered a molecular mechanism that may explain how differences between the sexes in neurological diseases in humans arise
Science website logo
SEARCH